- Home
- HVT vs ENGN Comparison
HVT vs ENGN Comparison
Compare HVT & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HVT | ENGN |
|---|---|---|
| Founded | 1885 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.1M | 379.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HVT | ENGN |
|---|---|---|
| Price | $24.66 | $7.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $22.71 |
| AVG Volume (30 Days) | 109.0K | ★ 437.5K |
| Earning Date | 10-29-2025 | 12-19-2025 |
| Dividend Yield | ★ 5.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $741,429,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $8.12 | N/A |
| P/E Ratio | $20.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.01 | $2.65 |
| 52 Week High | $25.27 | $11.14 |
Technical Indicators
Market Signals| Indicator | HVT | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.55 | 48.35 |
| Support Level | $24.49 | $8.05 |
| Resistance Level | $25.27 | $9.14 |
| Average True Range (ATR) | 0.74 | 0.60 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 66.86 | 16.88 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.